Aethlon Medical Inc (NASDAQ: AEMD)’s stock price has gone decline by -6.41 in comparison to its previous close of 0.41, however, the company has experienced a 0.26% increase in its stock price over the last five trading days. prnewswire.com reported 2025-03-10 that Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and Oncology Results Support Further Evaluation of the Hemopurifier ® as Part of a Machine Perfusion Circuit to Further Assess its Impact on the Function of Retrieved Kidneys SAN DIEGO, March 10, 2025 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases and for use in organ transplantation, today announced the publication of a pre-clinical study in the peer-reviewed journal Transplant Immunology (https://doi.org/10.1016/j.trim.2025.102215) on February 28, 2025, entitled, ” A lectin affinity plasmapheresis device removes extracellular vesicles and microRNAs from renal perfusates following controlled oxygenated rewarming of discarded donor kidneys.” Aethlon Medical’s Hemopurifier® is a therapeutic blood filtration system designed to bind and remove harmful extracellular vesicles and life-threatening viruses from blood and other biological fluids.
Is It Worth Investing in Aethlon Medical Inc (NASDAQ: AEMD) Right Now?
Additionally, the 36-month beta value for AEMD is 1.92. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for AEMD is 15.11M and currently, short sellers hold a 0.37% ratio of that float. The average trading volume of AEMD on May 01, 2025 was 255.62K shares.
AEMD’s Market Performance
AEMD’s stock has seen a 0.26% increase for the week, with a 6.42% rise in the past month and a -48.59% fall in the past quarter. The volatility ratio for the week is 10.09%, and the volatility levels for the past 30 days are at 9.31% for Aethlon Medical Inc The simple moving average for the past 20 days is 5.15% for AEMD’s stock, with a -16.53% simple moving average for the past 200 days.
AEMD Trading at -9.27% from the 50-Day Moving Average
After a stumble in the market that brought AEMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.72% of loss for the given period.
Volatility was left at 9.31%, however, over the last 30 days, the volatility rate increased by 10.09%, as shares surge +3.45% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -40.47% lower at present.
During the last 5 trading sessions, AEMD rose by +0.26%, which changed the moving average for the period of 200-days by -10.37% in comparison to the 20-day moving average, which settled at $0.3624. In addition, Aethlon Medical Inc saw -55.70% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for AEMD
The total capital return value is set at -0.0. Equity return is now at value -160.04, with -112.71 for asset returns.
Based on Aethlon Medical Inc (AEMD), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -8.24.
Currently, EBITDA for the company is -11.85 million with net debt to EBITDA at 437.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.77.
Conclusion
In conclusion, Aethlon Medical Inc (AEMD) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
